Skye Seeks Alliance To Advance Clinical Trials Of Rapid Stroke Assay
This article was originally published in The Gray Sheet
Executive Summary
Skye Pharmatech is looking to gain access to a large pool of subjects for trials of its stroke diagnostic tool through an agreement with a major diagnostic or pharmaceutical concern, the company says.